Probiotic potential of autochthonous Enterobacter mori ASP8 and Bacillus stercoris ASP10 isolated from gut microbiota of healthy stinging catfish, Heteropneustes fossilis (Bloch).
{"title":"Probiotic potential of autochthonous Enterobacter mori ASP8 and Bacillus stercoris ASP10 isolated from gut microbiota of healthy stinging catfish, Heteropneustes fossilis (Bloch).","authors":"Pritish Mitra, Somen Dey, Arindam Ganguly, Sabyasachi Chatterjee, Asish Mandal","doi":"10.1007/s00210-026-05360-3","DOIUrl":null,"url":null,"abstract":"<p><p>This study characterizes two bacterial isolates Enterobacter mori ASP8 and Bacillus stercoris ASP10, derived from the stinging catfish (Heteropneustes fossilis) and evaluates in vitro probiotic efficacy for enhancing sustainability in freshwater aquaculture. Rigorous biosafety assessments confirmed that both strains were non-hemolytic, were non-blood coagulant, lack DNase/RNase activity, and were non-biogenic amine producers. Both isolates exhibited high gastrointestinal resilience and survival under stimulated stomach duodenum passage (SSDP) with a value of 81.98% for E. mori ASP8 and 84.89% for B. stercoris ASP10. The isolates also showed strong tolerance to bile, phenol, and lysozyme. Functional assays revealed robust hydrocarbon adherence up to 84.83% and significant co-aggregation with fish pathogens varied between 50.5 and 72.69%. Notably, it was found that B. stercoris ASP10 exhibited biofilm-forming capabilities on Congo red agar. E. mori ASP8 and B. stercoris ASP10 showed strong antibacterial activity against seven pathogens by producing bacteriocin, siderophore production. In addition, the isolates exhibited cholesterol lowering, antioxidant potentially and multi-enzymatic (amylase, protease, cellulase, and lipase) activities. Overall findings concluded both strains are effective, but B. stercoris ASP10 emerged as superior probiotic candidate for future aquaculture application.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-026-05360-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This study characterizes two bacterial isolates Enterobacter mori ASP8 and Bacillus stercoris ASP10, derived from the stinging catfish (Heteropneustes fossilis) and evaluates in vitro probiotic efficacy for enhancing sustainability in freshwater aquaculture. Rigorous biosafety assessments confirmed that both strains were non-hemolytic, were non-blood coagulant, lack DNase/RNase activity, and were non-biogenic amine producers. Both isolates exhibited high gastrointestinal resilience and survival under stimulated stomach duodenum passage (SSDP) with a value of 81.98% for E. mori ASP8 and 84.89% for B. stercoris ASP10. The isolates also showed strong tolerance to bile, phenol, and lysozyme. Functional assays revealed robust hydrocarbon adherence up to 84.83% and significant co-aggregation with fish pathogens varied between 50.5 and 72.69%. Notably, it was found that B. stercoris ASP10 exhibited biofilm-forming capabilities on Congo red agar. E. mori ASP8 and B. stercoris ASP10 showed strong antibacterial activity against seven pathogens by producing bacteriocin, siderophore production. In addition, the isolates exhibited cholesterol lowering, antioxidant potentially and multi-enzymatic (amylase, protease, cellulase, and lipase) activities. Overall findings concluded both strains are effective, but B. stercoris ASP10 emerged as superior probiotic candidate for future aquaculture application.
期刊介绍:
Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.